Ticker Details
Rhythm Pharmaceuticals, Inc. Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
IPO Date:	October 5, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$5.88B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.87 | 2.89%
Avg Daily Range (30 D):	$2.54 | 2.88%
Avg Daily Range (90 D):	$2.49 | 2.51%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	.84M
Avg Daily Volume (90 D):	.69M

Trade Size
Avg Trade Size (Sh.):	67
Avg Trade Size (Sh.) (30 D):	55
Avg Trade Size (Sh.) (90 D):	52

Institutional Trades
Total Institutional Trades:	3,062
Avg Institutional Trade:	$2.85M
Avg Institutional Trade (30 D):	$4.83M
Avg Institutional Trade (90 D):	$5.4M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.17M
Avg Closing Trade (30 D):	$11.08M
Avg Closing Trade (90 D):	$11.6M
Avg Closing Volume:	102.11K

News

Apr 3, 2026 @ 1:00 PM Rhythm Pharmaceuticals Announces Changes to Board ... Source: Na

Mar 19, 2026 @ 10:30 PM Rhythm Pharmaceuticals Announces FDA Approval of I... Source: Rhythm Pharmaceuticals, Inc.

Mar 17, 2026 @ 12:33 PM Stock Market Today: Dow, S&P 500 Futures Tick Up A... Source: Rishabh Mishra

Mar 17, 2026 @ 11:12 AM Rhythm Pharmaceuticals Rare Obesity Drug Study Dis... Source: Vandana Singh

Mar 1, 2026 @ 5:30 PM Rhythm Pharmaceuticals Announces Additional Positi... Source: Rhythm Pharmaceuticals, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.11	$-.73	$-3.11
Diluted EPS	$-3.11	$-.73	$-3.11
Revenue	$189.76M	$57.25M	$189.76M
Gross Profit	$170.27M	$52.45M	$170.27M
Net Income / Loss	$-196.54M	$-47.51M	$-196.54M
Operating Income / Loss	$-192.02M	$-47.06M	$-192.02M
Cost of Revenue	$19.49M	$4.8M	$19.49M
Net Cash Flow	$-34.87M	$2.01M	$-34.87M
PE Ratio